LivaNova plc (LIVN) Tops Q3 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to LivaNova plc (LIVN) Tops Q3 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance

LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance

November 5, 2025 6:00 AM EST

Delivered double-digit reported and organic revenue growth and continued operating margin expansion

Raised full-year 2025 revenue, adjusted earnings per share, and adjusted free cash flow guidance(1)

Launched Essenz Perfusion System in China

LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the third quarter ended September 30, 2025 and raised full-year 2025 guidance.

Financial Summary and Highlights(1)

Third-quarter revenue of $357.8 million increased 12.5% on a reported basis, 11.0% on a constant-currency basis, and 12.5% on an organic... More